J Cahn

3.0k total citations
70 papers, 1.6k citations indexed

About

J Cahn is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, J Cahn has authored 70 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hematology, 15 papers in Oncology and 14 papers in Immunology. Recurrent topics in J Cahn's work include Hematopoietic Stem Cell Transplantation (34 papers), Acute Myeloid Leukemia Research (13 papers) and Chronic Myeloid Leukemia Treatments (13 papers). J Cahn is often cited by papers focused on Hematopoietic Stem Cell Transplantation (34 papers), Acute Myeloid Leukemia Research (13 papers) and Chronic Myeloid Leukemia Treatments (13 papers). J Cahn collaborates with scholars based in France, Switzerland and United Kingdom. J Cahn's co-authors include P Hervé, Didier Blaise, Nöel Milpied, Pierre Bordigoni, Norbert Ifrah, E Racadot, Josy Reiffers, Vernant Jp, Myriam Labopin and Éric Deconinck and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Immunological Reviews.

In The Last Decade

J Cahn

67 papers receiving 1.5k citations

Peers

Countries citing papers authored by J Cahn

Since Specialization

Citations

This map shows the geographic impact of J Cahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Cahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Cahn more than expected).

Fields of papers citing papers by J Cahn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Cahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Cahn. The network helps show where J Cahn may publish in the future.

Co-authorship network of co-authors of J Cahn

This figure shows the co-authorship network connecting the top 25 collaborators of J Cahn. A scholar is included among the top collaborators of J Cahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Cahn. J Cahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT 2016 ·Annals of Oncology ·Stephen Robinson, Ariane Boumendil, Hervé Finel, Harry C. Schouten, Gerhard Ehninger, Johan Maertens, Charles Crawley, Alessandro Rambaldi, Nigel H. Russell, (unknown), Didier Blaise, Ibrahim Yakoub‐Agha, Arnold Ganser, Luca Castagna, Liisa Volin, J Cahn, Silvia Montoto, (unknown)	20
2	Investigation of Pathogenic Escherichia coli and Microbial Pathogens in Pulp and Paper Mill Biosolids 2007 ·Water Environment Research ·Maxine C. Croteau, (unknown), Frederick S. Archibald, Valérie S. Langlois, J Cahn, Jeffrey J. Ridal, Vance L. Trudeau, D. R. S. Lean	7
3	A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) 2007 ·Leukemia ·Haifa Kathrin Al‐Ali, R. Brand, Anja van Biezen, Jürgen Finke, M. Boogaerts, AA Fauser, Maarten Egeler, J Cahn, R. Arnold, Harald Biersack, Dietger Niederwieser, T. de Witte	22
4	Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation 2003 ·Leukemia ·Mohamad Mohty, Karin Bilger, Éric Jourdan, Mathieu Kuentz, Mauricette Michallet, Jean Henri Bourhis, Nöel Milpied, Laurent Sutton, J. P. Jouet, Michel Attal, Pierre Bordigoni, J Cahn, Alain Sadoun, Norbert Ifrah, Denis Guyotat, Catherine Faucher, Nathalie Fegueux, Josy Reiffers, D Maraninchi, Didier Blaise	101
5	Prior treatment with alpha interferon does not adversely  affect the outcome of allogeneic transplantation  for chronic myeloid leukaemia 2002 ·British Journal of Haematology ·Arnaud Pigneux, M-L. Tanguy, Mauricette Michallet, J P Jouet, Mathieu Kuentz, Vernant Jp, Nöel Milpied, Norbert Ifrah, J Cahn, N Gratecos, Oumédaly Reman, H. Curé, Denis Caillot, Francis Witz, (unknown), P Tron, Josy Reiffers, (unknown)	15
6	Relationship between expression of genes involved in cell cycle control and apoptosis in diffuse large B cell lymphoma: a preferential survivin–cyclin B link 2002 ·Leukemia ·Fabien Kuttler, Marie‐Blanche Valnet‐Rabier, R Angonin, Christophe Ferrand, Éric Deconinck, Christiane Mougin, J Cahn, Thierry Fest	38
7	Polyvisceral arteritis in chronic graft-versus-host disease: antiphospholipid-negative thrombotic syndrome mimicking polyarteritis nodosa 2002 ·Bone Marrow Transplantation ·Loïc Ysebaert, Éric Deconinck, Fabrice Larosa, Denis Caillot, Pierre Tiberghien, Olivier Casasnovas, J Cahn	1
8	Peripheral stem cells are the preferred source of stem cells for autologous stem cell transplantation (ASCT) of young patients with MDS or AML following MDS: An analysis of the chronic leukaemia working party of the European blood and marrow transplantation group (EBMT) 2001 ·Blood ·T de Witte, R. Brand, Anja van Biezen, Michel Delforge, (unknown), Reuven Or, William Arcese, (unknown), Jorge Sierra, J Cahn, Marie‐Cécile Michallet, Sergio Amadori, D Niederwieser, Aloïs Gratwohl, (unknown)	4
9	Allogeneic peripheral blood stem cell transplantation results in less alteration of early T cell compartment homeostasis than bone marrow transplantation 2001 ·Bone Marrow Transplantation ·Hakim Tayebi, Pierre Tiberghien, Christophe Ferrand, (unknown), Anne Duperrier, J Cahn, V. Lapierre, Philippe Saas, Mathieu Kuentz, Didier Blaise, P Hervé, Éric Robinet	23
10	Effect of cell determinant (CD)34+ cell dose on the cost and consequences of peripheral blood stem cell transplantation for non-Hodgkin's lymphoma patients in front-line therapy 2000 ·European Journal of Cancer ·Samuel Limat, Marie-Christine Woronoff-Lemsi, Nöel Milpied, (unknown), Norbert Ifrah, Éric Deconinck, Rémy Gressin, Philippe Colombat, J Cahn, Patrick Arveux	19
11	Chronic myeloid leukemia in first chronic phase not responding to α-interferon: outcome and prognostic factors after autologous transplantation 1999 ·Bone Marrow Transplantation ·J.-M. Boiron, J Cahn, Giovanna Meloni, Carmelo Carlo‐Stella, Giuseppe Bandini, Oumédaly Reman, Nöel Milpied, Jane F. Apperley, Josy Reiffers, (unknown)	8
12	Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft 1999 ·Bone Marrow Transplantation ·Olle Ringdén, Myriam Labopin, Francesco Frassoni, Guillermo Sanz, F Deméocq, H. G. Prentice, J Cahn, Tiziano Barbui, G Meloni, (unknown), Josy Reiffers, (unknown), (unknown)	30
13	Prolonged remission and autologous recovery in two patients with chronic myelogenous leukemia after graft failure of allogeneic bone marrow transplantation 1998 ·Bone Marrow Transplantation ·L Fouillard, Éric Deconinck, Pierre Tiberghien, (unknown), Éric Solary, Francine Mugneret, A. Brion, P Hervé, J Cahn	11
14	Age-adapted induction treatment of acute lymphoblastic leukemia in the elderly and assessment of maintenance with interferon combined with chemotherapy. A multicentric prospective study in forty patients 1997 ·Leukemia ·André Delannoy, Catherine Sebban, Pascale Cony‐Makhoul, Bruno Cazin, Catherine Cordonnier, Réda Bouabdallah, J Cahn, François Dreyfus, Alain Sadoun, Vernant Jp, (unknown), A Broustet, Jl. Michaux, D Fière	25
15	Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM) 1997 ·British Journal of Haematology ·Gèrard Socié, J Cahn, (unknown), Vernant Jp, J. P. Jouet, Norbert Ifrah, Nöel Milpied, Mauricette Michallet, Bruno Lioure, J. L. Pico, Francis Witz, Lysiane Molina, Alain Fischer, V J Bardou, Éliane Gluckman, Josy Reiffers	96
16	Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan) 1997 ·Bone Marrow Transplantation ·Éric Deconinck, J Cahn, Nöel Milpied, J P Jouet, J P Vernant, Hélène Espérou, Bruno Lioure, Pierre Bordigoni, V. Leblond, Xavier Troussard, Denis Caillot, (unknown), P Hervé	22
17	Cost comparative study of autologous peripheral blood progenitor cells (PBPC) and bone marrow (ABM) transplantations for non-Hodgkin’s lymphoma patients 1997 ·Bone Marrow Transplantation ·(unknown), Patrick Arveux, Samuel Limat, Éric Deconinck, Pascal Morel, J Cahn	21
18	Recombinant alpha-interferon as treatment for chronic myelogenous leukemia in relapse after allogeneic bone marrow transplantation: a report from the Société Française de Greffe de Moelle. 1995 ·PubMed ·Arnaud Pigneux, A Devergié, (unknown), (unknown), E Archimbaud, J Cahn, (unknown), Marie‐Cécile Michallet, (unknown), François Guilhot	9
19	In situ hybridization for the detection of cytomegalovirus in blood or bone marrow leucocytes after allogeneic bone marrow transplantation 1994 ·British Journal of Haematology ·Thierry Fest, M Deschaseaux, Christiane Mougin, J Cahn, J.L. Dupond, P Hervé	4
20	Peripheral blood stem cell transplantation followed by recombinant alpha interferon for chronic myelogenous leukemia in chronic phase: Preliminary results 1993 ·Stem Cells ·Josy Reiffers, J Cahn, Marion Montastruc, Denis Caillot, G Souillet, (unknown), Jacques Troncy, C. Fabères	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact